Prognostic Tests for Estrogen Receptor-Positive Breast Cancer: Need for Global Consideration and Further Evolution

JAMA Oncol. 2016 Feb;2(2):180-2. doi: 10.1001/jamaoncol.2015.4343.

Authors

Jee Ye Kim¹, Seung-Il Kim¹, Soonmyung Paik²

Affiliations

¹ Department of Surgery, Yonsei University College of Medicine, Seoul, South Korea2Department of Breast Cancer Center, Yonsei University College of Medicine, Seoul, South Korea.
² Department of Breast Cancer Center, Yonsei University College of Medicine, Seoul, South Korea3Severance Biomedical Science Institute, Yonsei University College of Medicine, Seoul, South Korea4Division of Pathology, NSABP Foundation, Pittsburgh, Pennsylvan.

PMID: 26633601
DOI: 10.1001/jamaoncol.2015.4343

No abstract available

Publication types

Editorial
Comment

MeSH terms

Biomarkers, Tumor / analysis*
Biomarkers, Tumor / genetics*
Breast Neoplasms / chemistry*
Breast Neoplasms / genetics*
Female
Gene Expression Profiling / methods*
Humans
Immunohistochemistry*
Ki-67 Antigen / analysis*
Neoplasm Recurrence, Local*
Reverse Transcriptase Polymerase Chain Reaction*

Substances

Biomarkers, Tumor
Ki-67 Antigen